Composition


Main ingredients:lidocaine hydrochloride.
Chemical name: N- (dichloroxylyl) -2- (diethylamino) acetamide hydrochloride monohydrate
The molecular formula: c14h22n2o HCI h20
Molecular weight: 288.82

Character

This product is colorless and clear liquid.

Indication


This product is a local anesthetic and antiarrhythmic. It is mainly used for infiltration anesthesia, epidural anesthesia, surface anesthesia (including mucosal anesthesia during thoracoscopy or abdominal surgery) and nerve conduction block. This product can be used for ventricular premature beat and ventricular tachycardia after acute myocardial infarction, and can also be used for digitalis poisoning, cardiac surgery and ventricular arrhythmia caused by cardiac catheter. This product is usually ineffective for supraventricular arrhythmia.
adverse effect
(1) This product can act on the central nervous system, causing drowsiness, paresthesia, muscle tremor, convulsion coma, respiratory depression and other adverse reactions.
(2) It can cause hypotension and bradycardia. Excessive blood concentration can cause atrial conduction velocity to slow down, atrioventricular block, inhibit myocardial contractility and decrease cardiac output.

As a generic drug supplier in China, Feiyue Pharmaceutical can provide finished drugs such as Lidocaine Hydrochloride InjECTion
Packaging: 10ml:0.1g

FEIYUE recruits agents worldwide, we can provide complete registration documents.

Taboo

Matters need attention

Drug interaction

Pharmacology


This product is an amide local anesthetic. After blood absorption or intravenous administration, it has obvious biphasic effects of excitation and inhibition on central nervous system, and there is no precursor excitation. When the blood concentration is low, there will be analgesia, sleepiness and pain threshold increase. With the increase of dose, the effect or toxicity is enhanced, and the sub-toxic blood concentration has anticonvulsant effect; Convulsions can occur when the blood drug concentration exceeds 5ug/ml. At low dose, this product can promote the outflow of K+ in myocardial cells, reduce the self-discipline of myocardium, and have the effect of resisting ventricular arrhythmia. At the treatment dose, there was no obvious effect on the electrical activity of myocardial cells, atrioventricular conduction and myocardial contraction. The further increase of blood concentration can cause heart conduction velocity to slow down, atrioventricular block, inhibit myocardial contractility and decrease cardiac output.

Pharmacokinetics


After injection, the tissue is distributed quickly and widely, and it can penetrate the blood-brain barrier and placenta. This product has strong anesthetic intensity, quick effect and strong dispersing power. It takes about 2 hours for the drug to be eliminated locally, and the action time can be prolonged by adding epinephrine. Most of them were degraded by liver microsomal enzyme to monoethyl glycinamide xylene, which still had local anesthetic effect. The toxicity increased, and then they were hydrolyzed by amidase and excreted in urine. About 10% of the dosage was excreted in the original form, and a small amount appeared in bile.

Store up


Sealed storage.

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注